tsao-t has been researched along with foscarnet in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Camarasa, MJ; De Clercq, E; Koontz, DL; Lobatón, E; Mellors, JW; Velázquez, S | 1 |
| Félix, AS | 1 |
2 other study(ies) available for tsao-t and foscarnet
| Article | Year |
|---|---|
Hybrids of [TSAO-T]-[foscarnet]: The first conjugate of foscarnet with a non-nucleoside reverse transcriptase inhibitor through a labile covalent ester bond.
Topics: Cell Extracts; Cell Line, Tumor; Drug Resistance, Viral; Drug Stability; Foscarnet; HIV Reverse Transcriptase; HIV-1; Humans; Hydrolysis; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Thymidine; Uridine | 2004 |
Monitor-chemistry: antiretrovirals: the first [Foscarnet]-[TSAO-T] conjugates.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Foscarnet; HIV Reverse Transcriptase; HIV-1; Spiro Compounds; Thymidine; Uridine | 2005 |